Recruiting patients into clinical trials is one of – if not the – biggest problems facing the life sciences industry.

Given that clinical trials are the mechanism by which potential treatments are approved to be released for sale, and obviously this is a multi-billion dollar industry, why is it that patient recruitment is such a big problem? Well, in my experience, there are 3 main areas that cause the issues:

Firstly Awareness – or more accurately, lack of awareness that trials exist.

Secondly Access – again, more accurately, lack of access, with large populations of potential trial participants not being able to attend a suitable venue to take part in a trial.

And Thirdly Complexity – over time trials have become more complex, with multiple endpoints and increasingly restrictive inclusion/exclusion criteria.

On top of these, in the next video I’ll introduce a fundamental mindset shift that I believe is required in order to tackle these problems.

You may also like

Biotech C-suites Should keep Patient Recruitment in Mind from the Outset
In biotech, a strong C-suite isn’t just about job titles - it’s about covering every part of the journey from discovery to delivery. Including being prepared to tackle one of the biggest ...
Key C-suite Roles for Biotech Success - The Chief Patient Recruitment Officer (CPRO)
While biotech companies have built C-suites with scientific, medical, financial, operational, and business expertise, a critical function has remained conspicuously absent - addressing one ...
Key C-suite Roles for Biotech Success - The Chief Business Officer (CBO)
The Chief Business Officer leads external strategy - licensing deals, identifying pharma partnerships, and developing long-term growth planning and market positioning strategies that ...